MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Dissecting the Hierarchy of Tumor Cell Differentiation Using Dual Recombinase Technology in a Novel Mouse Model of Rhabdomyosarcoma |
Duke University Medical Center / David Van Mater, MD, PhD |
Young Investigator Grants |
2013 |
North Carolina |
Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer
Directed Therapy
|
Dana-Farber Cancer Institute / Andrew Hong, MD |
Young Investigator Grants |
2015 |
Massachusetts |
Deciphering the Mechanisms of Medulloblastoma Treatment Resistance using Integrative Genomics |
Hospital for Sick Children / Vijay Ramaswamy, MD |
Young Investigator Grants |
2014 |
Ontario |
Targeting the Rac GTPase Pathway to Sabotage RAS Signaling in RAS-mutated Leukemia |
Boston Children’s Hospital / Sara Canovas Nunes, PhD |
Young Investigator Grants |
2020 |
Massachusetts |
DFMO-based combination therapy for the treatment of advanced stage neuroblastoma.
|
Cancer Research Center of Hawaii / Dana-Lynn Koomoa |
Young Investigator Grants |
2009 |
Hawaii |
Defining the Molecular Mechanisms Underlying Pediatric Brain Tumor Penetrance |
Washington University / Nicole Brossier, MD/PhD |
Young Investigator Grants |
2019 |
Missouri |
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan / Mark Chiang |
Young Investigator Grants |
2011 |
Michigan |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |